DENIAL RESPONSE & PAYER INTELLIGENCE

Stronger responses.
Built from what you learn.

ClaimFortis is developing patent-pending technology to help providers prepare evidence-supported appeals, learn from reviewed outcomes, and make recurring payer problems visible.

Development stage · Seeking provider and RCM pilot partners
Read our October 19 development update →

Architectural illustration of a modern healthcare building
Stronger operations.
More support for care.
Conceptual imagery
FOR PROVIDERSEvaluate your denial workflowFOR RCM PARTNERSExplore payer intelligenceFOR STRATEGIC INVESTORSReview the business thesis

DEVELOPMENT UPDATE · OCTOBER 19, 2026

Clearer workflows.
A practical plan to measure value.

ClaimFortis remains in development. We have refined our proposed denial-response and payer-intelligence workflows and the plans for evaluating them with providers and RCM teams.

PAYER INTELLIGENCE

Connect requirements to outcomes.

Our proposed workflow links payer requirements, denial history, reviewed responses and actual payment outcomes. The goal is less repeated research and better-supported next steps, with human review before action.

PAYER ACCOUNTABILITY AND OUTCOMES EVIDENCE BANK

Build a traceable record.

We have defined a proposed evidence bank to organize recurring problems, supporting records and contrary evidence. It is intended to inform escalation and payer-contract discussions. A recurring problem alone does not establish misconduct.

MEASURING VALUE

Compare with the current process.

Our evaluation plans measure total staff effort, review burden, evidence quality and operating cost. Preparation time, payer response time and actual payment are separate measures. Reduced rework and correct reimbursement remain outcomes to evaluate.

Still in development.

These advances concern workflow design and evaluation planning. Live integration, customer results and ROI have not been established. Existing demonstrations use synthetic records; proposed pilots require further readiness review and agreed scope before execution.

Based on internal design and readiness reviews completed October 17–18, 2026.

Discuss your workflow
Earlier synthetic results · October 10, 2026

DENIAL REVIEW · STAGE A 1.1.3-rc1

Review, approve and export.

The local browser prototype supports current-case review, approval, revocation and saved case export. These checks cover a defined synthetic scope; production integration and performance remain unqualified.

PAYMENT & CONTRACT DISCREPANCIES

10 supported amounts. 3 withheld answers.

In 13 synthetic amount requests, the candidate returned amounts for the 10 designed answerable cases and correctly withheld answers for 3 indeterminate cases. Both conventional comparison methods matched it. This is finite conformance evidence, not superiority or a customer success rate.

DOCUMENT ACQUISITION

5 current useful acquisitions.

A separate synthetic assessment produced 5 current useful acquisitions across 11 predefined in-scope cases, from 12 presented cases. All compared approaches matched. No adaptive acquisition advantage or customer time savings was demonstrated.

ADMINISTRATIVE PREPARATION

4 current useful packets.

A separate synthetic worker produced 4 current useful packets across 7 predefined in-scope cases, from 8 presented cases. The endpoint was a prepared packet—not payer submission, a resolved denial or collected payment.

IDR & PRIOR AUTHORIZATION

Scope first. Validate next.

Independent dispute resolution (IDR) and prior authorization remain areas for scoped evaluation. The existing IDR illustration is not a maintained legal-rules service, an arbitration outcome or a live filing capability. Prior-authorization outcomes have not been validated.

ILLUSTRATIVE SCENARIO ANALYSIS

Assumptions to test with partners.

Our October 10 analysis explores denials, IDR and prior authorization using 85%, 90%, 95% and 99% first-pass assumptions. These are scenario inputs—not achieved performance, forecasts or promised outcomes. Clean-submission and favorable-decision views are separate and nonadditive. Calculation review does not validate real-world results.

What these results do—and do not—establish

These are separate evaluations; their counts must not be combined. The denial and payment components do not yet form a validated end-to-end product. The submission bridge remains a reviewed design on implementation hold, with unresolved findings. Live submission and receipt handling remain unimplemented in that design. Real payer outcomes, reimbursement improvement and staff-time savings remain unmeasured.

Evidence dates: October 8–10, 2026. Sources: internal payment-dispute, Stage A browser, acquisition and administrative-worker evaluations, plus a separate illustrative scenario analysis. Internal AI review is not independent external assurance or a customer study. The interactive examples on this public page remain illustrative simulations, not access to those prototypes.

Define a workflow evaluation

THE OPPORTUNITY

Care should not get buried
in denial administration.

When denial work becomes a cycle of record gathering, repeat responses, and unresolved follow-up, providers carry the burden. ClaimFortis aims to turn that experience into reusable knowledge—supporting faster responses, lower handling costs, and a clearer path toward reimbursement.

Learn from each outcome

Use reviewed denial reasons, response history, and outcomes to inform the next case. Recheck each response against current evidence and requirements.

Respond with less rework

Bring relevant records and prior response knowledge together sooner, with explicit gaps and customer approval of the exact outgoing packet.

Make payer patterns visible

Build a structured, reportable history of recurring denials, delays, and outcomes to support operational decisions and payer accountability.

PAYER INTELLIGENCE

See the pattern
behind the repeat work.

Explore how a structured denial history could reveal recurring problems across payer cohorts. Filter the fictional records to inspect unresolved cases and review where follow-up is needed.

SYNTHETIC PAYER REPORT

From individual cases to a reportable history.

12 invented records
Selected cases12 / 12
Unresolved5
Final outcomes7
Oldest unresolved case31 days
Fictional cases matching the selected filters
CasePayerReasonStatusDays*
SYN-001Fictional Payer ADocumentationUnresolved18
SYN-002Fictional Payer ADocumentationOverturned9
SYN-003Fictional Payer AAuthorizationUpheld14
SYN-004Fictional Payer AEligibilityUnresolved26
SYN-005Fictional Payer BDocumentationUpheld22
SYN-006Fictional Payer BAuthorizationUnresolved31
SYN-007Fictional Payer BDocumentationUnresolved12
SYN-008Fictional Payer BEligibilityOverturned17
SYN-009Fictional Payer CDocumentationOverturned11
SYN-010Fictional Payer CEligibilityUpheld15
SYN-011Fictional Payer CAuthorizationOverturned8
SYN-012Fictional Payer CDocumentationUnresolved6
What a real report should make visible

Repeated denial reasons, aging unresolved cases, and reviewed response outcomes—alongside their source records, cohort definitions, and follow-up status. An overturned denial alone does not establish that payment was received.

No real insurers or patients are represented. This small synthetic set cannot rank payer quality, establish trends, or estimate savings. A real reporting database would require authorized data, appropriate access controls, and validated definitions. The appeal explorer is a separate simulation; it does not alter these records.

THE APPEAL EXPLORER

Work the case.
Carry the learning forward.

Follow a fictional documentation denial from evidence to reviewed outcome. Then see what should—and should not—carry into the next case.

SYNTHETIC CASE / CF–001No real submission
  1. 1Check evidence
  2. 2Prepare & review
  3. 3Approve & send
  4. 4Record outcome
  5. 5Review learning

CASE ONE / FICTIONAL PAYER A

The payer says supporting documentation is missing.

The practice needs to check the source records, prepare a supported response, and approve the exact outgoing packet.

1 / EVIDENCE CHECK

Denial notice

Fictional Payer A requests documentation.

Encounter summary

Fictional service context; no patient information.

2 / REVIEW PACKET

The packet will appear after the supporting evidence is available. No missing clinical facts are invented.

3 / HUMAN REVIEW & CONTROLLED SUBMISSION

An explicit approval comes first.

Inspect the source excerpts and prepared packet before approving. Approval applies only to the version shown.

Prepare the packet first.

4. Choose a simulated payer outcome

An outcome can be recorded after receipt is confirmed.

5 / REVIEWED LEARNING

A better next response starts with a checked lesson.

Review the outcome and source context before making a lesson available. This example carries a checklist prompt forward; it does not train a model from one case.

An unresolved case cannot supply a final-outcome lesson.

Practice the failure paths: remove a source, revise an approved packet, leave a case unresolved, or change the next case’s requirements.

All cases, sources, payers, outcomes, and lessons are fictional. This browser simulation explains proposed workflow behavior; it is not the proprietary engine, a payer connection, a trained learning system, or evidence of reimbursement performance. State resets when you reload.
Discuss a private demonstration around your workflow

PARTNER PILOTS

Start focused.
Measure the full effort.

We are seeking provider and revenue-cycle partners to evaluate a denial-response workflow against their current process, with faster response, less rework, and better payer visibility as the goals.

One provider groupOne payerOne denial category
01

Agree the evaluation

Define the eligible case set, permitted data, baseline process, reviewers, and acceptance criteria.

02

Test preparation and learning

Measure response time and all human effort. Where scoped, test whether lessons from earlier cases help on a separate set without weakening evidence support.

03

Assess value and recurring patterns

Review operating cost, unresolved cases, and payer-pattern reporting. Establish reimbursement baselines and decide whether a prospective phase is warranted.

Initial evaluation is retrospective. Any sandbox or live submission phase requires a separately agreed scope and readiness decision.

WHAT A PILOT SHOULD ESTABLISH

Time to response

Can the team prepare and approve a supported response sooner after a denial arrives?

Time to reimbursement

Establish the historical baseline, then test whether an authorized prospective phase shortens the path to payment.

Administrative cost

Measure total effort per resolved case, including review, corrections, exceptions, and follow-up.

Recurring payer friction

Can structured reporting reveal recurring denial reasons, delays, unresolved balances, and outcomes that merit action?

These are evaluation objectives. Faster responses alone do not establish faster payment; reimbursement timing and savings require outcome data.

PARTNERS & INVESTORS

Better support for providers.
A clear way to participate.

The proposed platform connects evidence-supported denial responses with reviewed outcome learning and payer intelligence. Begin within a provider’s or revenue-cycle partner’s existing operation, then expand where the evidence supports value.

PROVIDERS & HEALTH SYSTEMS

Put the workflow to the test.

Bring one denial category and the team that handles it. Evaluate response time, total effort, and evidence quality against your current process.

Start with

A defined retrospective pilot and an agreed set of success measures.

Discuss a provider pilot

RCM & TECHNOLOGY PARTNERS

Strengthen your operation.

Explore a denial-response component within your existing customer relationships, queues, and approval process.

Start with

A capability fit discussion, integration scope, and proposed delivery model.

Explore an RCM partnership

STRATEGIC INVESTORS

Review the business thesis.

Explore a proposed licensed or embedded platform connecting denial-response preparation, reviewed outcome learning, and payer intelligence.

Start with

A discussion of pilot economics, validation milestones, and development needs.

Start an investor conversation
Begin with a defined pilot. Grow from measured value.

Licensing, embedded delivery, and wider payer reporting are proposed commercial paths. Each depends on validated results, integration readiness, and agreed data-use rights.

FOUNDER-LED. WORKFLOW-FOCUSED.

A physician’s perspective.
An operational mission.

Kevin Freels, MD

Founder & CEO · ClaimFortis Technologies

Kevin is an emergency physician and medical leader developing technology around evidence, accountability, and practical operational problems.

ClaimFortis brings that perspective to the provider side of reimbursement: less repeated administrative work, better-informed denial responses, and evidence that makes persistent payer problems visible.

EXPLORE AT THE RIGHT DEPTH

Start openly.
Go deeper by invitation.

Begin with the concept. As the fit becomes clearer, request a focused demonstration or a scoped technical discussion with the team.

PUBLIC / EXPLORE

Understand the possibilities.

Browse the capabilities, work through fictional scenarios, and review the proposed pilot approach.

  • High-level capabilities
  • Synthetic interactive examples
  • Pilot and partnership pathways
Explore the demonstration

PRIVATE / ENGAGE

Bring your use case.

Request a guided conversation tailored to your organization and the outcomes you want to evaluate.

  • Partner-fit discussion
  • Denial-workflow and reporting scoping
  • Proposed evaluation criteria
Request a private demonstration

RESTRICTED / EVALUATE

Make room for diligence.

Request a deeper review for an agreed partnership, pilot, or investment purpose.

  • Agreed review scope
  • Confidentiality terms before disclosure
  • Selected materials shared separately
Request a technical review

Private and restricted access begins with a reviewed request. Invitations, scope, and any confidentiality arrangements are agreed before materials are shared. Submitting a request does not unlock documents or grant system access.

LET’S EXPLORE THE FIT

Your workflow.
Our next conversation.

Tell us where denials, repeat work, delayed payment, or recurring payer patterns are burdening your operation—or introduce a partnership or investment interest.

Contact Kevin Freels directly at kfreels@claimfortistechnologies.com. Please send business information only; do not email patient records or confidential claim details.

Investor conversations are introductory; no investment terms are offered here.

Start a conversation.

Share your goal and the best way to reach you. Prefer email? Use one of the contact addresses alongside this form.

Please share business information only. Keep patient records, credentials, and confidential technical details out of this form.
Add role or timing (optional)

An inquiry does not create a pilot, investment, or service agreement.